[{"id":"c8dca8c7-a482-4d7b-823f-95465ef1e767","acronym":"","url":"https://clinicaltrials.gov/study/NCT05131763","created_at":"2021-11-23T13:53:39.639Z","updated_at":"2024-07-02T16:36:20.316Z","phase":"Phase 1","brief_title":"NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors","source_id_and_acronym":"NCT05131763","lead_sponsor":"Fudan University","biomarkers":" NKG2D","pipe":"","alterations":" ","tags":["NKG2D"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KD-025 CAR T-cells"],"overall_status":"Recruiting","enrollment":" Enrollment 3","initiation":"Initiation: 03/01/2021","start_date":" 03/01/2021","primary_txt":" Primary completion: 12/01/2022","primary_completion_date":" 12/01/2022","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2021-11-23"}]